Results 21 to 30 of about 634,130 (287)

Lack of Content Uniformity in MMR Vaccine. [PDF]

Contact Context, 2022
Isaacs JT, Almeter PJ, Henderson BS, Hunter AN, Platt TL, Lodder RA.   +5 more
europepmc   +3 more sources

Nurses' Perceptions Of MMR Vaccine Hesitancy In An Area With Low Vaccination Coverage. [PDF]

Pediatric Health Med Ther, 2019
Background and aim Measles, mumps, and rubella vaccine (MMR) coverage is low in an area in the Northern part of Stockholm, Sweden. The overall aim of this study was to explore the perceptions, views, and experiences of child health clinic nurses related ...
Jama A, Lindstrand A, Ali M, Butler R, Kulane A.   +4 more
europepmc   +2 more sources

Nurses’ Perceptions Of MMR Vaccine Hesitancy In An Area With Low Vaccination Coverage

Pediatric Health, Medicine and Therapeutics, 2019
Asha Jama,1,2 Ann Lindstrand,3 Mona Ali,1 Robb Butler,4 Asli Kulane2 1The Public Health Agency of Sweden, Stockholm, Sweden; 2Equity and Health Policy Research Group, Department of Public Health Sciences, Karolinska Institute, Stockholm, Sweden ...
Jama A, Lindstrand A, Ali M, Butler R, Kulane A   +4 more
doaj   +1 more source

Seronegative Vaccinees May Not Benefit From Multiple Booster Doses of MMR Vaccine in Restoring Immunity. [PDF]

J Med Virol
Anichini G, Terrosi C, Alessandri G, Miceli GB, Borrelli E, Fabrizi S, Savellini GG, Cusi MG.   +7 more
europepmc   +3 more sources

MMR vaccine coverage and associated factors among overseas-born refugee children resettled in Aotearoa New Zealand: a national retrospective cohort study. [PDF]

Lancet Reg Health West Pac, 2023
Charania NA, Paynter J, Turner N.
europepmc   +2 more sources

Transcriptional signatures associated with rubella virus-specific humoral immunity after a third dose of MMR vaccine in women of childbearing age. [PDF]

Eur J Immunol, 2021
Haralambieva IH, Eberhard KG, Ovsyannikova IG, Grill DE, Schaid DJ, Kennedy RB, Poland GA.   +6 more
europepmc   +3 more sources

Early MMR Vaccine Adoption During the 2025 Texas Measles Outbreak. [PDF]

JAMA Netw Open
Goodwin Cartwright BM, Masters NB, Gilbert KM, Rodriguez PJ, Do D, Stucky N.   +5 more
europepmc   +2 more sources

Comparison of Effectiveness and Safety of Immunotherapy of Warts with Intralesional Versus Subcutaneous MMR Vaccine: An Open Label Randomized, Parallel Group, Clinical Trial.

Indian J Dermatol, 2022
Saha A, Bahalia I, Agarwal S, Banerjee A, Bandyopadhyay D.   +4 more
europepmc   +2 more sources

Complete Regression of Anogenital Warts Following Intralesional Measles-Mumps-Rubella (MMR) Vaccine: A Case of Two. [PDF]

Clin Cosmet Investig Dermatol
Achdiat PA, Dwigunasari PR, Suwarsa O, Tsaqilah L, Maharani RH.   +4 more
europepmc   +3 more sources

Response to Measles, Mumps and Rubella (MMR) Vaccine in Transfusion-Dependent Patients. [PDF]

Vaccines (Basel), 2021
Casale M, Di Maio N, Verde V, Scianguetta S, Di Girolamo MG, Tomeo R, Roberti D, Misso S, Perrotta S.   +8 more
europepmc   +3 more sources